Learn / HALO
NASDAQ: HALO
Halozyme Therapeutics (HALO) stock, explained like you're 5
Halozyme Therapeutics trades on the Nasdaq under the ticker HALO. It is a large cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 12.5 billion dollars.
- Ticker
- HALO
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Biological Products (No Diagnostic Substances)
- Size
- Large cap, about 12.5 billion dollars
Is Halozyme Therapeutics a small, medium or large cap company?
Yes. Halozyme Therapeutics is a large cap stock. Its market cap, which is the total value of all its shares, is about 12.5 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Halozyme Therapeutics makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves HALO stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Here's How Much a $1000 Investment in Halozyme Therapeutics Made 10 Years Ago Would Be Worth Today (Yahoo Finance)
- HALO Stock Climbs As Patent Win And Targets Fuel Momentum (Timothy Sykes)
- Tesla: Roadster Shows Unique Technology That Will Make a Strong Halo Car (Morningstar)
- HALO Stock Climbs As Patent Win And Deals Lift Outlook (StocksToTrade)
- Missed Halozyme Therapeutics' 82% Run? What Holders Saw (Simply Wall Street)
Follow HALO in your daily brief
Each trading day at 5 PM ET we post what happened to Halozyme Therapeutics and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow HALO
Questions about Halozyme Therapeutics stock
What does Halozyme Therapeutics do?
Halozyme Therapeutics trades on the Nasdaq under the ticker HALO. It is a large cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 12.5 billion dollars.
What is the ticker symbol for Halozyme Therapeutics?
Halozyme Therapeutics trades under the ticker HALO on the Nasdaq.
What is Halozyme Therapeutics's market cap?
Halozyme Therapeutics is a large cap stock with a market cap of about 12.5 billion dollars.
How does Halozyme Therapeutics make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves HALO stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow HALO stock every day?
Add HALO to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.